Peter M. Hecht 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-28 9:47 pm Purchase |
2025-03-25 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 1,028,086 27.900% |
187,187 (+22.26%) |
Filing |
| 2023-12-05 4:00 pm Purchase |
2023-11-30 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 840,899 26.900% |
322,435 (+62.19%) |
Filing |
| 2023-05-23 4:00 pm Purchase |
2023-05-19 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Peter M. Hecht | 518,464 19.990% |
518,464 (New Position) |
Filing |